HLTRF
Price
$3.66
Change
+$0.44 (+13.66%)
Updated
Jun 4 closing price
Capitalization
153.75M
INCR
Price
$1.56
Change
+$0.08 (+5.41%)
Updated
Jul 3 closing price
Capitalization
123.5M
42 days until earnings call
Interact to see
Advertisement

HLTRF vs INCR

Header iconHLTRF vs INCR Comparison
Open Charts HLTRF vs INCRBanner chart's image
HLS Therapeutics
Price$3.66
Change+$0.44 (+13.66%)
Volume$100
Capitalization153.75M
Intercure
Price$1.56
Change+$0.08 (+5.41%)
Volume$25.22K
Capitalization123.5M
HLTRF vs INCR Comparison Chart in %
Loading...
HLTRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HLTRF vs. INCR commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLTRF is a Hold and INCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (HLTRF: $3.66 vs. INCR: $1.56)
Brand notoriety: HLTRF and INCR are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: HLTRF: 43% vs. INCR: 192%
Market capitalization -- HLTRF: $153.75M vs. INCR: $123.5M
HLTRF [@Pharmaceuticals: Other] is valued at $153.75M. INCR’s [@Pharmaceuticals: Other] market capitalization is $123.5M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLTRF’s FA Score shows that 1 FA rating(s) are green whileINCR’s FA Score has 1 green FA rating(s).

  • HLTRF’s FA Score: 1 green, 4 red.
  • INCR’s FA Score: 1 green, 4 red.
According to our system of comparison, HLTRF is a better buy in the long-term than INCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLTRF’s TA Score shows that 2 TA indicator(s) are bullish while INCR’s TA Score has 3 bullish TA indicator(s).

  • HLTRF’s TA Score: 2 bullish, 2 bearish.
  • INCR’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, HLTRF is a better buy in the short-term than INCR.

Price Growth

HLTRF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while INCR (@Pharmaceuticals: Other) price change was +4.70% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.92%. For the same industry, the average monthly price growth was +1.46%, and the average quarterly price growth was +84.86%.

Reported Earning Dates

INCR is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.92% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLTRF($154M) has a higher market cap than INCR($124M). HLTRF YTD gains are higher at: 36.059 vs. INCR (-1.887). INCR has higher annual earnings (EBITDA): 25.8M vs. HLTRF (15.8M). INCR has more cash in the bank: 103M vs. HLTRF (21.2M). HLTRF has less debt than INCR: HLTRF (95.2M) vs INCR (163M). INCR has higher revenues than HLTRF: INCR (415M) vs HLTRF (61.7M).
HLTRFINCRHLTRF / INCR
Capitalization154M124M124%
EBITDA15.8M25.8M61%
Gain YTD36.059-1.887-1,911%
P/E RatioN/A22.52-
Revenue61.7M415M15%
Total Cash21.2M103M21%
Total Debt95.2M163M58%
FUNDAMENTALS RATINGS
HLTRF vs INCR: Fundamental Ratings
HLTRF
INCR
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
59
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9484
PRICE GROWTH RATING
1..100
4257
P/E GROWTH RATING
1..100
1004
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HLTRF's Valuation (29) in the null industry is in the same range as INCR (59) in the Servicestothe Health Industry industry. This means that HLTRF’s stock grew similarly to INCR’s over the last 12 months.

HLTRF's Profit vs Risk Rating (100) in the null industry is in the same range as INCR (100) in the Servicestothe Health Industry industry. This means that HLTRF’s stock grew similarly to INCR’s over the last 12 months.

INCR's SMR Rating (84) in the Servicestothe Health Industry industry is in the same range as HLTRF (94) in the null industry. This means that INCR’s stock grew similarly to HLTRF’s over the last 12 months.

HLTRF's Price Growth Rating (42) in the null industry is in the same range as INCR (57) in the Servicestothe Health Industry industry. This means that HLTRF’s stock grew similarly to INCR’s over the last 12 months.

INCR's P/E Growth Rating (4) in the Servicestothe Health Industry industry is significantly better than the same rating for HLTRF (100) in the null industry. This means that INCR’s stock grew significantly faster than HLTRF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HLTRFINCR
RSI
ODDS (%)
Bearish Trend 5 days ago
47%
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
53%
Bearish Trend 5 days ago
85%
Momentum
ODDS (%)
N/A
Bullish Trend 5 days ago
75%
MACD
ODDS (%)
Bearish Trend 5 days ago
43%
Bullish Trend 5 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
49%
Bullish Trend 5 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
49%
Bearish Trend 5 days ago
79%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 5 days ago
87%
Aroon
ODDS (%)
Bullish Trend 5 days ago
51%
Bearish Trend 5 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
HLTRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSGNX6.500.07
+1.09%
MassMutual Small Cap Gr Eq R3
GABUX5.000.03
+0.60%
Gabelli Utilities AAA
SHPAX19.300.10
+0.52%
Saratoga Health & Biotechnology A
OAYBX37.480.05
+0.13%
Oakmark Equity and Income Advisor
AFGPX18.74N/A
N/A
Alger International Opportunities B

HLTRF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLTRF has been loosely correlated with PHCUF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if HLTRF jumps, then PHCUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLTRF
1D Price
Change %
HLTRF100%
N/A
PHCUF - HLTRF
38%
Loosely correlated
N/A
INCR - HLTRF
21%
Poorly correlated
+5.41%
GTBIF - HLTRF
3%
Poorly correlated
-0.36%
ESALF - HLTRF
3%
Poorly correlated
N/A
INDV - HLTRF
2%
Poorly correlated
+0.06%
More

INCR and

Correlation & Price change

A.I.dvisor tells us that INCR and PHCUF have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INCR and PHCUF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INCR
1D Price
Change %
INCR100%
+5.41%
PHCUF - INCR
26%
Poorly correlated
N/A
KMDA - INCR
24%
Poorly correlated
+1.81%
TLRY - INCR
22%
Poorly correlated
+11.03%
QNTM - INCR
22%
Poorly correlated
-10.96%
AKAN - INCR
21%
Poorly correlated
+5.38%
More